起的SARS-CoV-2 JN.1变种:演变,传染性,免疫逃脱和应对策略
Yishan Lu1, Danyi Ao1, Xuemei He1
1State Key Laboratory of Biotherapy West China Hospital Sichuan University Sichuan People's Republic of China.
MedComm
|July 31, 2024
概括
作为BA.2.86后裔的JN.1 COVID-19变种显示出由于L455S.等突变导致的传染性增加和免疫逃避. 目前的疫苗和抗体可能对这种主导菌株的有效性有所降低.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 公共卫生 公共卫生
背景情况:
- 作为BA.2.86的后裔,JN.1变种在2023年底成为全球占主导地位的COVID-19菌株.
- JN.1 具有独特的突变,包括 L455S 在它的受体结合基因中,有助于增强传染性和免疫逃避.
- 观察到对单克隆抗体的耐药性和XBB.1.5疫苗的中和性降低凸显了对JN.1特征的担忧.
研究的目的:
- 提供对正在演变的JN.1变种的全面审查.
- 评估当前针对JN.1和其他新兴变种的疫苗和治疗方法的疗效,特别是在免疫受损的个体中.
- 总结疫苗和治疗方法的潜在进展,以优化COVID-19的预防和管理.
主要方法:
- 科学出版物和公共卫生数据的文献综述.
- 分析突变概况及其对病毒特征的影响.
- 对疫苗和治疗疗效的临床数据的评估.
主要成果:
- JN.1 呈现出增强的传染性和免疫逃避性质.
- 已注意到现有的单克隆抗体和XBB.1.5疫苗对JN.1的有效性降低.
- 虽然立即的公共卫生威胁被认为是低的,但在免疫压力下的持续演变需要保持警.
结论:
- 持续监测JN.1和其他新兴变种对于公共卫生至关重要.
- 当前疫苗和治疗方法的有效性需要持续评估,特别是在脆弱人群中.
- 对疫苗进展和临床治疗的进一步研究对于有效打击COVID-19至关重要.
更多相关视频
相关概念视频
00:36Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
01:29Immune Response Against Viral Pathogens
766
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
766
00:57Viral Recombination
23.3K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.3K
01:05Single Nucleotide Polymorphisms-SNPs
14.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
14.9K
01:20Infection
7.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.8K
00:50What are Viruses?
114.5K
Overview
114.5K